Multidisciplinary Approaches Shape Treatment Pathways in EGFR-Mutated NSCLC

Emerging data in the neoadjuvant setting and the expansion of testing in standard practice have presented questions surrounding screening for and developing strategies from variant information in EGFR-mutated resectable non–small cell lung cancer.

Related Keywords

Chicago ,Illinois ,United States ,American ,Gustavo Cumbo Nacheli ,Kashish Saxena ,Nicholas Rohs ,Zofia Piotrowska ,Onclive Peer Exchange ,American Society Of Clinical Oncology Annual Meeting ,Moon Lee ,Wild West ,Clinical Oncology Annual Meeting ,Lung Cancer ,News ,Publication ,Lung ,Egfr Mutated ,